Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
FDA Approval of Semaglutide for MASH Marks a Turning Point in Liver Care A Global Burden: MASLD and MASH Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as NAFLD, affects roughly 30% of adults worldwide
Piazza is a board-certified plastic surgeon practicing in Austin, TX
Mantzoros, Mazen Noureddin, Karn Wijarnpreecha Liver International .2026;[Epub] CrossRef The Acetylcholine Esterase Inhibitor Donepezil Increases Dopamine Levels in the Nucleus Accumbens and Blocks the Alcohol Deprivation Effect in Rats Anna Loftn, Klara Danielsson, Louise Adermark, Bo Sderpalm, Mia Ericson Addiction Biology .2026;[Epub] CrossRef MetALD at the crossroads of metabolic and alcohol-related liver disease Gustavo Ayares, Luis Antonio Daz, Juan Pablo Arab, Marco Arrese Trends in Endocrinology & Metabolism .2026;[Epub] CrossRef Alcohol-Consumption Animal Models in Neurological Disease Research: A Review of Development, Current Status, and Prospects Biyun Cao, Rong Zhang, Yalang Deng, Yuxin Wang, Shiyun Jin Neuropharmacology and Therapy .2026;[Epub] CrossRef The emerging role of FGF21 in alcohol consumption and dependence: mechanisms and therapeutic prospects Simranpreet Kaur, Khadga Raj Aran Gene .2026
Common Signs a Weight-Loss Plan May Be Sacrificing Muscle Patients using GLP-1 medications or aggressive dieting should watch for signs that weight loss may be moving too fast or becoming too depleting
US$ 22.08
US$ 28.71
US$ 25.26
US$ 23.25
US$ 27.99
US$ 25.39
US$ 24.60
US$ 28.18
